Mahinay, Joella Mae S.

HRN: 18-62-91  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFUROXIME 1.5GM (VIAL)
10/17/2023
10/19/2023
IVT
1.5g
IVT Now ANST Then Q8
G2P1 (1000) 42 2/7 Weeks AOG By LMP; T/C Meconium Stained Amniotic Fluid Via UTZ
Waiting Final Action 
10/19/2023
CEFUROXIME 500MG (TAB)
10/19/2023
10/26/2023
PO
500mg
BID X 7 Days
T/c Meconium Stained Amniotic Fluid
Checking Final Appropriateness 
10/23/2023
CEFUROXIME 500MG (TAB)
10/23/2023
10/30/2023
PO
1 Tab
BID
SP NSVD; MSAF Thickly
Checking Final Appropriateness 
10/23/2023
METRONIDAZOLE 500MG (TAB)
10/23/2023
10/31/2023
PO
1 Tab
TID
SP NSVD: MSAF THICKLY
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: